World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
45
Citations
6922
World Ranking
4717
National Ranking
2128

Jorge C. G. Blanco publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Jorge C. G. Blanco sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 98 publications — 2nd percentile

2% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Jorge C. G. Blanco D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Jorge C. G. Blanco sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 45 D-Index — 6th percentile

6% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Jorge C. G. Blanco is affiliated with Sigmovir Biosystems in the United States, contributing extensively to biomedical research with a primary focus on medicine and infectious diseases. Their work spans several specialized subfields, including epidemiology, immunology, neurology, and molecular biology.

The scientist's research emphasizes respiratory viral infections, viral gastroenteritis, immune response and inflammation, influenza virus studies, plant virus studies, neonatal respiratory health, and interferon and immune responses.

A selection of recent papers authored or co-authored by Jorge C. G. Blanco includes:

  • Targeting TLR4 Signaling to Blunt Viral-Mediated Acute Lung Injury, 2021, Frontiers in Immunology
  • Early or Late Bacterial Lung Infection Increases Mortality After Traumatic Brain Injury in Male Mice and Chronically Impairs Monocyte Innate Immune Function, 2020, Critical Care Medicine
  • Classical Drug Digitoxin Inhibits Influenza Cytokine Storm, With Implications for Covid-19 Therapy, 2020, In Vivo
  • A mouse model of human TLR4 D299G/T399I SNPs reveals mechanisms of altered LPS and pathogen responses, 2020, The Journal of Experimental Medicine
  • Protection against influenza-induced Acute Lung Injury (ALI) by enhanced induction of M2a macrophages: possible role of PPARγ/RXR ligands in IL-4-induced M2a macrophage differentiation, 2022, Frontiers in Immunology

The frequent coauthors collaborating with Jorge C. G. Blanco include:

  • Marina S. Boukhvalova
  • Kari Ann Shirey
  • Stefanie N. Vogel
  • Arash Kamali
  • Fatoumata Y. D. Sylla

Jorge C. G. Blanco's publications appear regularly in several scientific journals, with multiple contributions to:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Frontiers in Immunology
  • Scientific Reports
  • Viruses
  • Human Vaccines & Immunotherapeutics

The scholarly output of this researcher reflects a broad commitment to understanding mechanisms underlying infectious and inflammatory diseases, especially focusing on viral pathogens affecting the respiratory system and immune system dynamics.

Best Publications

  • The histone acetylase PCAF is a nuclear receptor coactivator

    Jorge C G Blanco;Saverio Minucci;Jianming Lu;Xiang Jiao Yang

  • The TLR4 antagonist Eritoran protects mice from lethal influenza infection

    Kari Ann Shirey;Wendy Lai;Alison J. Scott;Michael Lipsky

  • Distinct Mutations in IRAK-4 Confer Hyporesponsiveness to Lipopolysaccharide and Interleukin-1 in a Patient with Recurrent Bacterial Infections

    Andrei E. Medvedev;Arnd Lentschat;Arnd Lentschat;Douglas B. Kuhns;Jorge C.G. Blanco

  • Analysis of TLR4 polymorphic variants: new insights into TLR4/MD-2/CD14 stoichiometry, structure, and signaling.

    Prasad Rallabhandi;Jessica Bell;Marina S. Boukhvalova;Andrei Medvedev

  • Association of TLR4 polymorphisms with symptomatic respiratory syncytial virus infection in high-risk infants and young children.

    Agnes A. Awomoyi;Prasad Rallabhandi;Toni I. Pollin;Eva Lorenz

  • Control of RSV-induced lung injury by alternatively activated macrophages is IL-4R|[alpha]|-, TLR4-, and IFN-|[beta]|-dependent

    Kari Ann Shirey;Lioubov M. Pletneva;Adam C. Puche;Achsah D. Keegan

  • Transcription factor TFIIB and the vitamin D receptor cooperatively activate ligand-dependent transcription.

    J. C. G. Blanco;I-Ming Wang;S. Y. Tsai;Ming-Jer Tsai

  • Interferon Regulatory Factor (Irf)-1 and Irf-2 Regulate Interferon γ–Dependent Cyclooxygenase 2 Expression

    Jorge C. G. Blanco;Cristina Contursi;Cindy A. Salkowski;David L. DeWitt

  • The cotton rat provides a useful small-animal model for the study of influenza virus pathogenesis.

    Martin G. Ottolini;Jorge C. G. Blanco;Maryna C. Eichelberger;David D. Porter

  • IL-12 Is Dysregulated in Macrophages from IRF-1 and IRF-2 Knockout Mice

    Salkowski Ca;Kopydlowski K;Blanco J;Cody Mj

  • The cotton rat model of respiratory viral infections

    Marina S. Boukhvalova;Gregory A. Prince;Jorge C.G. Blanco

  • Respiratory Syncytial Virus Fusion Protein-Induced Toll-Like Receptor 4 (TLR4) Signaling Is Inhibited by the TLR4 Antagonists Rhodobacter sphaeroides Lipopolysaccharide and Eritoran (E5564) and Requires Direct Interaction with MD-2

    Prasad Rallabhandi;Rachel L. Phillips;Marina S. Boukhvalova;Lioubov M. Pletneva

  • Pathogenesis of human metapneumovirus lung infection in BALB/c mice and cotton rats.

    Marie-Ève Hamelin;Kevin Yim;Katie H. Kuhn;Rose P. Cragin

  • The TLR4 agonist, monophosphoryl lipid A, attenuates the cytokine storm associated with respiratory syncytial virus vaccine-enhanced disease.

    Marina S. Boukhvalova;Gregory A. Prince;Layla Soroush;Dolores C. Harrigan

  • TLR4 antagonist FP7 inhibits LPS-induced cytokine production and glycolytic reprogramming in dendritic cells, and protects mice from lethal influenza infection

    Laure Perrin-Cocon;Anne Aublin-Gex;Stefania E. Sestito;Kari Ann Shirey

  • Mutations in the 1,25-dihydroxyvitamin D3 receptor identifying C- terminal amino acids required for transcriptional activation that are functionally dissociated from hormone binding, heterodimeric DNA binding, and interaction with basal transcription factor IIB, in vitro

    Peter W. Jurutka;Jui Cheng Hsieh;Lenore S. Remus;G. Kerr Whitfield

  • Cytokine and chemokine gene expression after primary and secondary respiratory syncytial virus infection in cotton rats.

    Jorge C. G. Blanco;Joann Y. Richardson;Miriam E. R. Darnell;Anne Rowzee

  • Combination anti-inflammatory and antiviral therapy of influenza in a cotton rat model.

    Martin Ottolini;Jorge Blanco;David Porter;Lisa Peterson

  • A live RSV vaccine with engineered thermostability is immunogenic in cotton rats despite high attenuation.

    Christopher C. Stobart;Christina A. Rostad;Zunlong Ke;Rebecca S. Dillard

  • Respiratory syncytial virus (RSV) infection induces cyclooxygenase 2: a potential target for RSV therapy.

    Joann Y. Richardson;Martin G. Ottolini;Lioubov Pletneva;Marina Boukhvalova

  • New Insights for Development of a Safe and Protective RSV Vaccine

    Jorge C G Blanco;Marina S Boukhvalova;Kari Ann Shirey;Gregory A Prince

Frequent Co-Authors

Stefanie N. Vogel
Stefanie N. Vogel University of Maryland, Baltimore
Gregory A. Prince
Gregory A. Prince National Institutes of Health
Keiko Ozato
Keiko Ozato Eunice Kennedy Shriver National Institute of Child Health and Human Development
Trudy G. Morrison
Trudy G. Morrison University of Massachusetts Chan Medical School
Otto Haller
Otto Haller University of Freiburg
Martin L. Moore
Martin L. Moore Emory University
Saverio Minucci
Saverio Minucci European Institute of Oncology
Moshe Arditi
Moshe Arditi Cedars-Sinai Medical Center
Christopher L. Karp
Christopher L. Karp Bill & Melinda Gates Foundation
Peter W. Jurutka
Peter W. Jurutka Arizona State University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in expanding their expertise within immunology, exploring related online degrees can open up promising career paths. Many professionals in the healthcare field pursue specialized programs such as acute care nurse practitioner programs to transition into more focused roles involving patient care in critical settings.

Accelerated options are popular among students seeking a faster route into nursing and advanced practice roles. Programs like accelerated NP programs provide an efficient pathway for those already holding a bachelor’s degree to become nurse practitioners with expertise applicable to immunology-related fields.

For individuals coming from non-nursing backgrounds, there are flexible options such as online ADN programs for non nurses, enabling entry into nursing careers while balancing other responsibilities. These programs serve as a strong foundation for further specialization.

Additionally, many students seek out the most accessible routes, making accelerated nursing programs near me a valuable resource. These programs often offer practical, hands-on learning experiences needed for those aiming to integrate immunology knowledge into clinical practice sooner.

Best Scientists Citing Jorge C. G. Blanco

Trending Scientists